Recently, CCL21 and SPARC-like protein 1 (SPARCL1/MAST9/hevin/SC-1) have demonstrated to be associated with drug resistance in ovarian cancer [125]. The gene discussed is SPARCL1; the disease is ovarian carcinoma.